• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Targacept Inc

+ Add to Watchlist

TRGT:US

2.7600 USD 0.0100 0.36%

As of 20:10:00 ET on 08/29/2014.

Snapshot for Targacept Inc (TRGT)

Open: 2.7900 Day's Range: 2.7200 - 2.7900 Volume: 83,456
Previous Close: 2.7700 52wk Range: 2.6800 - 6.1100 1-Yr Rtn: -46.09%

Stock Chart for TRGT

No chart data available.
  • TRGT:US 2.7600
  • 1D
  • 1M
  • 1Y
2.7700
Interactive TRGT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TRGT

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.3551
Est. EPS (USD) (12/2014) -1.0870
Est. PEG Ratio -
Market Cap (M USD) 93.27
Shares Outstanding (M) 33.79
30 Day Average Volume 274,261
Price/Book (mrq) 0.7971
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TRGT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TRGT

Targacept Inc. is a a biopharmaceutical company engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting neuronal nicotinic acetylcholine receptors.

Stephen Anthony Hill "Steve"President/CEOAlan A MussoSenior VP:Finance/CFO/Treasurer
Patrick C RockSenior VP/Secy/General CounselDavid A HosfordVP:Clinical Dev & Regulatory
More Company Profile & Key Executives for TRGT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil